Pharmaxis to acquire Topigen in equity deal
12 January 2010
Ian Haydock
Please Login to read the full article.
12 January 2010
Ian Haydock
ian.haydock@informa.com
Pharmaxis is to acquire the private Canadian firm Topigen Pharmaceuticals in an all-stock transaction which will add to its development pipeline in the respiratory area.
The Australian company will issue 3.2 million shares on the closing of the deal, with another five million shares to...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Partnering discussions continue as Verona's RPL554 shows promise in COPD
- With $14M new funding in hand, Pulmatrix takes on COPD, cystic fibrosis
- FDA delays Alexza’s inhaled antipsychotic on 'major’ NDA amendment
- Alexza blows up on FDA concerns over lung risks with inhaled antipsychotic
FEATURES
Other Informa Features
EVENTS
Today
London
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
